Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-Trelin for Ataxia in Spinocerebellar Degeneration
NCT04107740Phase 4Completed
- Sponsor
- HLB Pharma
- Start
- Mar 2019
- Primary completion
- Feb 2021
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clindamycin + tretinoin in spinocerebellar degeneration (SCD), sponsored by HLB Pharma. Started Mar 2019; status: completed.
02
Drugs
clindamycin + tretinoin
03
Conditions
spinocerebellar degeneration (SCD)
Beyond the preview
Go deeper on NCT04107740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04107740.